* Bio Path Holdings Inc BPTH.OQ reported a quarterly
adjusted
loss of 47 cents per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 45 cents per share.
* Reported revenue was zero; analysts expected zero.
* Bio Path Holdings Inc's reported EPS for the quarter was a
loss
of 47 cents.
* The mean earnings estimate of analysts had fallen by
about 26.4%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Bio Path Holdings Inc shares had fallen by 16.9% this
quarter and lost 15.4% so far this year.
* The company reported a quarterly loss of $3.36 million.
* Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $12.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 17 at 01:31 p.m. All
figures in US dollars unless otherwise stated